Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
5.17
+0.17 (3.40%)
At close: Mar 6, 2026, 4:00 PM EST
8.05
+2.88 (55.71%)
After-hours: Mar 6, 2026, 7:59 PM EST
Atara Biotherapeutics Employees
Atara Biotherapeutics had 153 employees as of December 31, 2024. The number of employees decreased by 72 or -32.00% compared to the previous year.
Employees
153
Change (1Y)
-72
Growth (1Y)
-32.00%
Revenue / Employee
$3,998,158
Profits / Employee
$615,816
Market Cap
37.28M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Xilio Therapeutics | 64 |
| Palatin Technologies | 29 |
| Jasper Therapeutics | 27 |
| Lisata Therapeutics | 26 |
| Actinium Pharmaceuticals | 25 |
| PDS Biotechnology | 24 |
| Veru Inc. | 20 |
| Sensei Biotherapeutics | 15 |
ATRA News
- 4 days ago - Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel - Business Wire
- 12 days ago - Atara Biotherapeutics Provides a Business Update - Business Wire
- 7 weeks ago - Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel) - Business Wire
- 4 months ago - Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress - Business Wire
- 4 months ago - Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) - PRNewsWire
- 5 months ago - 4 Biotechnology Stocks That Outshine In Momentum Amid Strong Technicals - Benzinga
- 6 months ago - Atara Biotherapeutics Announces Changes to Its Board of Directors - Business Wire
- 7 months ago - Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress - Business Wire